DATAROMA
Home
Commentaries/Articles
Superinvestors
Activity
S&P500 Grid
Grand Portfolio
RealTime
Insider
28 Sep 2015
Ron Muhlenkamp: Rhetoric risk in biotech will continue
( Portfolio )
Ron Muhlenkamp, Muhlenkamp Fund founder and portfolio manager, provides perspective on where to invest and the current state of the U.S. economy.
Home
Help notes
Contact
Terms of Service
Privacy